Dr. Hamilton Discusses Trastuzumab deruxtecan - NBCLX

Sarah Cannon breast cancer and gynecologic cancer expert, Dr. Erika Hamilton joined NBLX to discuss Trastuzumab deruxtecan, which is part of a new class of medicines working to use targeted chemotherapy to only attack the cancer cell.